Impact BioMedical Inc. (NYSE American: IBO)

✨ ICYMI: Catch the Impact BioMedical (NYSE American: IBO) management team as they delve into their four core platform technologies and explain how these align with the company’s unique business model! ✨ You can view the full live webinar hosted on November 20th here: https://lnkd.in/ewZ82H4s

🌟 Join Us for a Live Event with Impact Biomedical Inc. - Led by CEO Frank D. Heuszel! 🌟 Want to learn more about one of the latest biotechnology IPO's to come to market in 2024? Don’t miss out on this exclusive opportunity to hear from Frank D. Heuszel, CEO of Impact Biomedical Inc., as he shares their journey from concept to real-world impact and highlights what the future holds! Don’t miss out, sign up today! ✅ #impactbio #biotech #innovation #NYSE #IBO

🌟 Join Us for a Live Event with Impact Biomedical Inc. - Led by CEO Frank D. Heuszel! 🌟 Want to learn more about one of the latest biotechnology IPO's to come to market in 2024? Don’t miss out on this exclusive opportunity to hear from Frank D. Heuszel, CEO of Impact Biomedical Inc., as he shares their journey from concept to real-world impact and highlights what the future holds! Don’t miss out, sign up today! ✅ #impactbio #biotech #innovation #NYSE #IBO

Impact BioMedical Inc. (NYSE American: IBO) is proud to announce our participation in the upcoming Spartan Capital Securities, LLC Investor Conference 2024 on November 4th at The Pierre Hotel, New York City.   With our leadership team, including Frank D. Heuszel, Mark Suseck, and Todd Macko, CPA, we are excited to engage with conference attendees and share our latest advancements.   Special thanks to our hosts at Spartan Capital for bringing together an incredible lineup of public company executives and institutional investors. For those interested in attending, you can request to participate here: https://lnkd.in/e6ZQhZyA.    We look forward to seeing you there!  

Impact BioMedical Inc. (NYSE American: IBO) is driving healthcare innovation with scientifically-backed, nature-inspired solutions. Our breakthrough antiviral candidate, Equivir, has demonstrated potential in inhibiting a wide range of viruses. Additionally, our LineBacker platform offers novel approaches to combat drug resistance in cancer treatments, enhancing patient outcomes.    Through rigorous research and advanced biotechnology, we’re delivering tangible solutions that bridge the gap between nature and cutting-edge science.   https://lnkd.in/e7ePcugd   #HealthcareInnovation #AntiviralResearch #BiotechSolutions #SustainableHealthcare #NatureInspiredScience #PatientOutcomes #CancerTherapies #AdvancedBiotechnology #ImpactfulResearch #PlantBasedMedicine

Impact BioMedical Inc. (#NYSE American: #IBO) Announces #IPO Participation with Strong Support from Partners and Affiliates   Impact BioMedical Inc. (NYSE American: IBO), a pioneering #biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, is pleased to announce the successful completion of its Initial Public Offering (IPO). Notable is that over 30% of the IPO was purchased by existing investors which further demonstrates strong belief in the company and its potential.   Frank D. Heuszel, CEO of Impact BioMedical, commented, "The significant participation of our investors underscores their confidence in our mission and the innovative healthcare solutions we are developing. Their support is a testament to the value they see in our work and our potential to make a meaningful impact on human health."   https://lnkd.in/ecAcqWzp

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue Impact BioMedical Inc. (NYSE American: IBO) is proud to announce that the U.S. Patent and Trademark Office has issued U.S. Patent No. 11,985,973, entitled “Insect Repelling Composition.” This patent was developed within our 3F™ technology platform and follows the previously granted U.S. Patent No. 11,246,310. The natural compositions within 3F™ “blind” insects to human presence by inhibiting their olfactory receptors. Potential applications include mosquito repellents and additives for products like detergents, shampoos, and lotions, making outdoor activities safer and more enjoyable. https://lnkd.in/eY5kNp4r #ImpactBioMedical #3FTechnology #PatentIssue #HealthcareInnovation #InsectRepellent #NaturalProducts #NYSE #Biopharma 

Frank D. Heuszel Mark Suseck Todd Macko, CPA Impact BioMedical Inc. (NYSE American: IBO) #IBO

Impact BioMedical Inc. (NYSE American: #IBO), a pioneering #biotechnology company dedicated to discovering, developing, and patenting unique #healthcare solutions, is pleased to introduce its executive leadership team, poised to lead the company through its next phase of innovation and growth.   https://lnkd.in/eWfumanY   Impact BioMedical Inc. (NYSE American: IBO) Frank D. Heuszel Mark Suseck Todd Macko, CPA

DSS, Inc. (NYSE American: DSS) Celebrates Impact BioMedical Inc. (NYSE American: IBO)'s Successful IPO and Proudly Advances Shareholder Value   https://lnkd.in/eP9YHyAM   #DSS #ImpactBioMedical #IPO #ShareholderValue #Biotech #PublicOffering #Investment #Growth #Innovation #Business